Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management
Since their invention in the early 2000s, tyrosine kinase inhibitors (TKIs) have gained
prominence as the most effective pathway-directed anti-cancer agents. TKIs have shown …
prominence as the most effective pathway-directed anti-cancer agents. TKIs have shown …
Management of common clinical problems experienced by survivors of cancer
Improvements in early detection and treatment have led to a growing prevalence of survivors
of cancer worldwide. Models of care fail to address adequately the breadth of physical …
of cancer worldwide. Models of care fail to address adequately the breadth of physical …
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic …
ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …
that, unless otherwise provided for by national regulations, offlabel use of medication should …
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools …
AR Lyon, S Dent, S Stanway, H Earl… - European journal of …, 2020 - Wiley Online Library
This position statement from the Heart Failure Association of the European Society of
Cardiology Cardio‐Oncology Study Group in collaboration with the International Cardio …
Cardiology Cardio‐Oncology Study Group in collaboration with the International Cardio …
Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
Remarkable progress has been made in the development of new therapies for cancer,
dramatically changing the landscape of treatment approaches for several malignancies and …
dramatically changing the landscape of treatment approaches for several malignancies and …
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the H eart F ailure A ssociation (HFA), the E …
Cardiovascular (CV) imaging is an important tool in baseline risk assessment and detection
of CV disease in oncology patients receiving cardiotoxic cancer therapies. This position …
of CV disease in oncology patients receiving cardiotoxic cancer therapies. This position …
Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association
Cardiovascular disease (CVD) remains the leading cause of mortality in women, yet many
people perceive breast cancer to be the number one threat to women's health. CVD and …
people perceive breast cancer to be the number one threat to women's health. CVD and …
Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 1
Modern cancer therapy has successfully cured many cancers and converted a terminal
illness into a chronic disease. Because cancer patients often have coexisting heart …
illness into a chronic disease. Because cancer patients often have coexisting heart …
Cardiovascular disease in women: clinical perspectives
Cardiovascular disease continues to be the leading cause of death among women in the
United States, accounting for≈ 1 of every 3 female deaths. Sex-specific data focused on …
United States, accounting for≈ 1 of every 3 female deaths. Sex-specific data focused on …
Cardio-Oncology Services: rationale, organization, and implementation: A report from the ESC Cardio-Oncology council
Aims Anticancer therapies have extended the lives of millions of patients with malignancies,
but for some this benefit is tempered by adverse cardiovascular (CV) effects. Cardiotoxicity …
but for some this benefit is tempered by adverse cardiovascular (CV) effects. Cardiotoxicity …